Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-06 pm EDT 		5-day change 1st Jan Change
20.67 USD -1.38% Intraday chart for Organon & Co. -1.29% +43.34%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Bullish

Neutral

Resistance 21.96 21.96 23.15
Spread/Res.-5.87%-5.87%-10.71%
Spread/Supp.+1.47%+33.35%+87.57%
Support 20.37 15.50 11.02

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Charts Organon & Co.